Tumor microenvironment and therapeutic response

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

Microenvironmental regulation of tumor progression and metastasis

Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994

Macrophage Diversity Enhances Tumor Progression and Metastasis

Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,338

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632

Fibroblasts in cancer

Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538

Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759

Coordinated regulation of myeloid cells by tumours

Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544

Immunogenic Cell Death in Cancer Therapy

Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463

Macrophage plasticity and polarization in tissue repair and remodelling

Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384

Tumor microenvironment-responsive thermoelectric scaffold for on-demand antitumor therapy

Gao, X., Deng, W., Tan, J., Shuai, X., Zan, J., Ye, T., Luo, K.-W., Qi, F., Wei, Y., & Shuai, C. (2024) · Materials Today Chemistry · doi:10.1016/j.mtchem.2024.102455 · Cited by 40

Recent advances of anti-tumor nano-strategies via overturning pH gradient: alkalization and acidification

Gong, Q., Song, X., Tong, Y., Huo, L., Zhao, X., Han, Y., Shen, W., Ru, J., Shen, X., & Liang, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03134-2 · Cited by 47

Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment

Liu, L., Li, Y., & Li, B. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189344 · Cited by 44

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer

Bessone, M. I. D., Gattas, M. J., Laporte, T., Tanaka, M., & Simian, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00547 · Cited by 40

Past, Present, and Future of Anticancer Nanomedicine

Kim, K., & Khang, D. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254774 · Cited by 39

Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models

Ringquist, R., Ghoshal, D., Jain, R., & Roy, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114003 · Cited by 39

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

Landuzzi, L., Manara, M. C., Lollini, P.-L., & Scotlandi, K. (2021) · Cells · doi:10.3390/cells10020416 · Cited by 39

Analysis of the relationship between preoperative serum tumor marker levels and tumor immune scores in patients with colorectal cancer based on nano-electrochemiluminescence

Pan, S., Niu, B., Tao, Y., Xia, G., Huang, L., Xu, J., Zhu, L., & Cao, H. (2021) · Materials Express · doi:10.1166/mex.2021.2063 · Cited by 39

Construction of a novel blood brain barrier-glioma microfluidic chip model: Applications in the evaluation of permeability and anti-glioma activity of traditional Chinese medicine components

Shi, Y., He, X., Wang, H., Dai, J., Fang, J., He, Y., Chen, X., Hong, Z., & Chai, Y. (2022) · Talanta · doi:10.1016/j.talanta.2022.123971 · Cited by 40

Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment

Knipper, K., Lyu, S. I., Quaas, A., Bruns, C. J., & Schmidt, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713482 · Cited by 41

Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies

Najafi, S., & Mortezaee, K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122387 · Cited by 39

Metal–Organic Framework Nanocomposites in Conquering Hypoxia for Tumor Therapy

Zhou, S., Jia, F., Wei, Y., Du, J., Liu, J., Dong, W., Sui, J., Xue, W., Yang, Y., Chen, L., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202314012 · Cited by 40

Influence of the gut microbiota on immune cell interactions and cancer treatment

Liu, C., Fu, L., Wang, Y., & Yang, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05709-3 · Cited by 47

Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway

Kang, Y., Hu, W., Bai, E., Zheng, H., Liu, Z., Wu, J., Jin, R., Zhao, C., & Liang, G. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s118272 · Cited by 39

Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer

Guan, Y., Du, Y., Wang, G., Gou, H., Xue, Y., Xu, J., Li, E., Chan, D. W., Wu, D., Xu, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673295 · Cited by 38

Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer

Chen, S., Tsuneyama, K., Yen, M., Lee, J., Chen, J.-L., & Huang, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-91454-2 · Cited by 39

Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment

Li, Z., Ning, F., Wang, C., Yu, H., Ma, Q., & Sun, Y. (2021) · Nanoscale · doi:10.1039/d1nr03387e · Cited by 39

Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression

Shimizu, M., Koma, Y., Sakamoto, H., Tsukamoto, S., Kitamura, Y., Urakami, S., Tanigawa, K., Kodama, T., Higashino, N., Nishio, M., et al. (2021) · Cancers · doi:10.3390/cancers13184552 · Cited by 41

Nano-constructs targeting the primary cellular energy source of cancer cells for modulating tumor progression

Yadav, D. K., Singh, D., Singh, M. R., & Pradhan, M. (2022) · OpenNano · doi:10.1016/j.onano.2022.100107 · Cited by 39

Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy

Lan, M., Lü, W., Zou, T., Li, L., Liu, F., Cai, T., & Cai, Y. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03696-4 · Cited by 39

Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker

Hu, X., Zhu, H., Zhang, X., He, X., & Xu, X. (2021) · Cancer Medicine · doi:10.1002/cam4.4203 · Cited by 41

AMPK: An odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene

Penugurti, V., Mishra, Y. G., & Manavathi, B. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188785 · Cited by 39

The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma

Park, Y., Lee, D., Lee, J. E., Park, H. S., Jung, S. S., Park, D., Kang, D. H., Lee, S., Woo, S., & Chung, C. (2024) · Cancers · doi:10.3390/cancers16030598 · Cited by 42

Two dimensional carbon based nanocomposites as multimodal therapeutic and diagnostic platform: A biomedical and toxicological perspective

Dhas, N. L., Parekh, K., Pandey, A. P., Kudarha, R. R., Mutalik, S., & Mehta, T. A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.016 · Cited by 38

Colorectal Cancer Stem Cells in the Progression to Liver Metastasis

González-Villarreal, C. A., Quiroz-Reyes, A. G., Islas, J. F., & Garza-Treviño, E. N. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01511 · Cited by 42

Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments

Li, S., Liu, M., Ma, H., Jin, Q., Ma, Y., Wang, C., Ren, J., Liu, G., & Dai, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-020-00763-z · Cited by 38

Precise Depletion of Tumor Seed and Growing Soil with Shrinkable Nanocarrier for Potentiated Cancer Chemoimmunotherapy

Wang, J., Shen, S., Li, J., Cao, Z., & Yang, X. (2021) · ACS Nano · doi:10.1021/acsnano.0c08996 · Cited by 38

Blood–Brain Barrier, Cell Junctions, and Tumor Microenvironment in Brain Metastases, the Biological Prospects and Dilemma in Therapies

Guan, Z., Lan, H., Cai, X., Zhang, Y., Liang, A., & Li, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722917 · Cited by 39

The Hypoxia‐Related Gene COL5A1 Is a Prognostic and Immunological Biomarker for Multiple Human Tumors

Zhu, H., Hu, X., Feng, S., Jian, Z., Xu, X., Gu, L., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6419695 · Cited by 44

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

Li, X.-M., Zhao, Z., Xiao, Y., Xia, Q., Zhou, P., Wang, S., Wu, H., & Hu, J. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00394-2 · Cited by 40

Cancer cell states and emergent properties of the dynamic tumor systemPreprint

Barkley, D., Rao, A. N., Pour, M., França, G. S., & Yanai, I. (2021) · Genome Research · doi:10.1101/gr.275308.121 · Cited by 39

The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer

Chen, R., Zou, J., Kang, R., & Tang, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0236 · Cited by 39

The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

Lu, Y., Lin, B., & Li, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1363695 · Cited by 41

Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma

Pan, L., Fang, J., Chen, M., Zhai, S., Zhang, B., Jiang, Z., Juengpanich, S., Wang, Y., & Cai, X. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i8.789 · Cited by 37

Wnt signalling pathway in bladder cancer

Wu, G., Weng, W., Xia, P., Yan, S., Zhong, C., Xie, L., Xie, Y., & Fan, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109886 · Cited by 36

Multi-Omics Data Analysis of Gene Expressions and Alterations, Cancer-Associated Fibroblast and Immune Infiltrations, Reveals the Onco-Immune Prognostic Relevance of STAT3/CDK2/4/6 in Human Malignancies

Lawal, B., Lin, L.-C., Lee, J., Chen, J.-H., Bekaii‐Saab, T., Wu, A. T. H., & Ho, C. (2021) · Cancers · doi:10.3390/cancers13050954 · Cited by 38

Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy

Liao, Y., He, D., & Wen, F. (2021) · Immunogenetics · doi:10.1007/s00251-021-01223-8 · Cited by 36

Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer

Yang, T., Zhang, Z., Zhang, J., Li, Y., Li, W., Liang, H., & Yang, F. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01684 · Cited by 37

Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment

Tu, Y., Gong, J., Mou, J., Jiang, H., Zhao, H., & Gao, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1434137 · Cited by 36

Screening TCGA database for prognostic genes in lower grade glioma microenvironment

Ni, J., Liu, S., Qi, F., Xiao, L., Yu, S., Feng, J., & Zheng, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.01.73 · Cited by 35

Interferon-Induced Protein 44 Correlated With Immune Infiltration Serves as a Potential Prognostic Indicator in Head and Neck Squamous Cell Carcinoma

Pan, H., Wang, X., Huang, W., Dai, Y., Yang, M. Y., Liang, H., Wu, X., Zhang, L., Huang, W., Lü, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.557157 · Cited by 36

Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer

Yu, D., Yang, X. N., Lin, J., Cao, Z., Lu, C., Yang, Z., Zheng, M., Pan, R., & Cai, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.724655 · Cited by 38

Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage

Cui, X., Wang, Q., Zhou, J., Wang, Y., Xu, C., Tong, F., Wang, H., & Kang, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.710695 · Cited by 38

Antitumor effect of a polysaccharide from Pseudostellaria heterophylla through reversing tumor-associated macrophages phenotype

Pu, Y., Zhu, J., Xu, J., Zhang, S., & Bao, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.111 · Cited by 36

Construction and Validation of a Novel Pyroptosis-Related Gene Signature to Predict the Prognosis of Uveal Melanoma

Cao, Y., Xie, J., Liang, C., Hu, Y., Zhai, L., Yuan, J., Suo, L., Shen, Y., Ye, R., Li, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.761350 · Cited by 35

Targeting redox regulation and autophagy systems in cancer stem cells

Khan, S. U., Rayees, S., Sharma, P., & Malik, F. A. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00955-5 · Cited by 36

EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer

Chen, Y., Zhu, H., Luo, Y., Tong, S., & Liu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116624 · Cited by 36

Neutrophil extracellular traps promote invasion and metastasis via NLRP3-mediated oral squamous cell carcinoma pyroptosis inhibition

Zhai, R., Gong, Z., Wang, M., Ni, Z., Zhang, J., Wang, M., Zhang, Y., Zeng, F., Gu, Z., Chen, X., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01982-9 · Cited by 38

α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages

Matsusaka, K., Fujiwara, Y., Pan, C., Esumi, S., Saito, Y., Bi, J., Nakamura, Y., Mukunoki, A., Takeo, T., Nakagata, N., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3471 · Cited by 34

A pan-cancer analysis revealed the role of the SLC16 family in cancer

Li, J., Xie, J., Wu, D., Chen, L., Gong, Z., Wu, R., Hu, Y., Zhao, J., & Xu, Y. (2021) · Channels · doi:10.1080/19336950.2021.1965422 · Cited by 35

Immune Microenvironment and Response in Prostate Cancer Using Large Population Cohorts

Ren, X., Chen, X., Zhang, X., Jiang, S., Zhang, T., Li, G., Lü, Z., Zhang, D., Wang, S., & Qin, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686809 · Cited by 35

M2 Macrophage Derived Extracellular Vesicle-Mediated Transfer of MiR-186-5p Promotes Colon Cancer Progression by Targeting DLC1

Guo, J., Wang, X., Guo, Q., Zhu, S., Li, P., Zhang, S., & Min, L. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69405 · Cited by 34

Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues

Song, Q., Ye, Y., Jiang, D., Qin, Z., Xu, C., Wang, H., Huang, J., Chen, L., Luo, R., Zhang, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31719-0 · Cited by 35

CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis

Li, Y., Han, S., Wu, B., Zhong, C., Shi, Y., Lv, C., Fu, L., Zhang, Y., Lang, Q., Liang, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951247 · Cited by 35

Posttranslational control of lipogenesis in the tumor microenvironment

Zhu, Y., Lin, X., Zhou, X., Prochownik, E. V., Wang, X., & Li, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01340-1 · Cited by 39

Deep learning in digital pathology for personalized treatment plans of cancer patients

Wen, Z., Wang, S., Yang, D. M., Xie, Y., Chen, M., Bishop, J., & Xiao, G. (2023) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2023.02.003 · Cited by 34

Nanosystems for chemodynamic based combination therapy: Strategies and recent advances

Li, M., Zhang, W., Xu, X., Liu, G., Dong, M., Sun, K., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1065438 · Cited by 35

Epigenetic regulation of pyroptosis in cancer: Molecular pathogenesis and targeting strategies

Zhang, R., Jing, Z.-Q., Zhang, L., & Sun, Z. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216413 · Cited by 34

Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor

Teng, Q., Lei, Z., Wang, J., Yang, Y., Wu, Z., Acharekar, N., Zhang, W., Yoganathan, S., Pan, Y., Wurpel, J. N. D., et al. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101028 · Cited by 34

Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review

Restrepo, J. C., Guevara, D. M., López, A. P., Palacios, J. F. M., & Liscano, Y. (2024) · Cancers · doi:10.3390/cancers16132338 · Cited by 35

Co-evolution of glioma and immune microenvironment

Elguindy, M. M., Young, J. S., Ho, W. S., & Lu, R. O. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009175 · Cited by 39

Fibroblast Activation Protein (FAP)+ cancer-associated fibroblasts induce macrophage M2-like polarization via the Fibronectin 1-Integrin α5β1 axis in breast cancer

Chen, W., Jiang, M., Zou, X., Chen, Z., Shen, L., Hu, J., Kong, M., Huang, J., Ni, C., & Xia, W. (2025) · Oncogene · doi:10.1038/s41388-025-03359-3 · Cited by 34

A survey of herbal medicines as tumor microenvironment‐modulating agents

Park, C., Lee, J., Son, C., & Lee, N. (2020) · Phytotherapy Research · doi:10.1002/ptr.6784 · Cited by 34

Eukaryotic translation initiation factor 5A in the pathogenesis of cancers (Review)

Ning, L., Wang, L., Zhang, H., Jiao, X., & Chen, D. (2020) · Oncology Letters · doi:10.3892/ol.2020.11942 · Cited by 38

Heme oxygenase 1: a novel oncogene in multiple gynecological cancers

Lu, J.-J., Abudukeyoumu, A., Zhang, X. Y., Liu, L., Li, M., & Xie, F. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.61073 · Cited by 34

Marine bacterial exopolysaccharide EPS11 inhibits migration and invasion of liver cancer cells by directly targeting collagen I

Liu, G., Liu, R., Shan, Y., & Sun, C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101133 · Cited by 36

A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration

Mirzaei, N. M., Su, S., Sofia, D., Hegarty, M., Abdel‐Rahman, M. H., Asadpoure, A., Cebulla, C. M., Chang, Y. H., Hao, W., Jackson, P., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11101031 · Cited by 37

Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules

Costantino, M., Corno, C., Colombo, D., & Perego, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.889816 · Cited by 34

Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment

Zhu, L., Meng, D., Wang, X., & Chen, X. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00199 · Cited by 35

Epigenetic and Immunological Features of Bladder Cancer

Gilyazova, I. R., Enikeeva, K., Альбертовна, Р. Г., Марсельевна, К. Э., Вакилевна, Ш. Ю., Динаровна, А. Д., & Павлов, В. Н. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129854 · Cited by 34

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers

Li, P., Wang, N., Zhang, Y., Wang, C., & Du, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791535 · Cited by 33

In Situ Cocktail Nanovaccine for Cancer Immunotherapy

Liu, M., Xie, D., Hu, D., Zhang, R., Wang, Y., Tang, L., Zhou, B., Zhao, B., & Yang, L. (2023) · Advanced Science · doi:10.1002/advs.202207697 · Cited by 32

Single-cell transcriptomic analyses of tumor microenvironment and molecular reprograming landscape of metastatic laryngeal squamous cell carcinoma

Sun, Y., Chen, S., Lu, Y., Xu, Z., Fu, W., & Yan, W. (2024) · Communications Biology · doi:10.1038/s42003-024-05765-x · Cited by 33

Tumor Microenvironment-Activatable Nanosystem Capable of Overcoming Multiple Therapeutic Obstacles for Augmenting Immuno/Metal-Ion Therapy

Cheng, Q., Shi, X., Chen, Y., Li, Q., Wang, J., Li, H., Wang, L., & Wang, Z. (2024) · ACS Nano · doi:10.1021/acsnano.3c12745 · Cited by 33

Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway

Wei, T., Cong, X., Wang, X., Xu, X.-J., Min, S., Ye, P., Peng, X., Wu, L., & Yu, G. (2016) · Oncotarget · doi:10.18632/oncotarget.14255 · Cited by 34

Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication

Lee, G., Park, H., Sohn, I., Lee, S.-H., Song, S. H., Kim, H. S., Lee, K. S., Shim, Y. M., & Lee, H. Y. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0538 · Cited by 33

Sorafenib-loaded hydroxyethyl starch-TG100-115 micelles for the treatment of liver cancer based on synergistic treatment

Li, G., & Zhao, L. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1642418 · Cited by 33

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma

Han, L., Shi, H., Luo, Y., Sun, W., Li, S., Zhang, N., Jiang, X., Gong, Y. Q., & Xie, C. (2020) · Cancer Medicine · doi:10.1002/cam4.3561 · Cited by 33

Wnt Signaling in the Tumor Microenvironment

Ruan, Y., Ogana, H. A. N., Gang, E., Kim, H. N., & Kim, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_7 · Cited by 35

Regulation of Antitumor Immune Responses by Exosomes Derived from Tumor and Immune Cells

Rincón‐Riveros, A., López, L., Villegas, V. E., & Rodrı́guez, J. A. (2021) · Cancers · doi:10.3390/cancers13040847 · Cited by 33

miRNAs mediated drug resistance in hematological malignancies

da Silva, S. P., Caires, H. R., Bergantim, R., Guimarães, J. E., & Vasconcelos, M. H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.014 · Cited by 36

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer

Cao, R., Ma, B., Wang, G., Xiong, Y., Tian, Y., & Yuan, L. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.06.011 · Cited by 33

Progress in Redirecting Antiparasitic Drugs for Cancer Treatment

Huang, H., He, Q., Bing-hua, G., Xu, X., Wu, Y., & Li, X. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s308973 · Cited by 35

PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

Rong, X., Jin-yu, L., Liu, Y., Wang, Z., Zeng, D., Li, Y., Li, S., Wu, J., Shen, Z., Shi, M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.802257 · Cited by 34

A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect

Li, X., Zeng, L., Gu, S., & Zhao, X. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04951-0 · Cited by 33

Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma

Zhou, Y., Li, X., Long, G., Tao, Y., Zhou, L., & Tang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.994259 · Cited by 35

Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage

Wei, F., Fang, R., Lyu, K., Liao, J., Long, Y., Yang, J., Wen, W., & Sun, W. (2023) · Oral Oncology · doi:10.1016/j.oraloncology.2023.106532 · Cited by 34

Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer

Zhao, H., Yin, X., Wang, L., Liu, K., Liu, W., Bo, L., & Wang, L. (2023) · Scientific Data · doi:10.1038/s41597-023-02032-2 · Cited by 38

Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer

Zou, Q., Lei, X., Xu, A., Li, Z., He, Q., Huang, X., Xu, G., Tian, F., Ding, Y., & Zhu, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.724139 · Cited by 33

Melittin-incorporated nanomedicines for enhanced cancer immunotherapy

Duan, X., Zou, H., Yang, J.-Z., Liu, S., Xu, T., & Ding, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.047 · Cited by 35

Identification prognosis-associated immune genes in colon adenocarcinoma

Miao, Y., Wang, J., Ma, X., Yang, Y., & Mi, D. (2020) · Bioscience Reports · doi:10.1042/bsr20201734 · Cited by 32

Tumor Microenvironment Triggered Cascade‐Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma

Xin, F., Wu, M., Cai, Z., Zhang, X., Wei, Z., Liu, X., & Liu, J. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002036 · Cited by 32

3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept

Samadian, H., Jafari, S., Sepand, M. R., Alaei, L., Malvajerd, S. S., Jaymand, M., Ghobadinezhad, F., Jahanshahi, F., Hamblin, M. R., Derakhshankhah, H., et al. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100160 · Cited by 33

JAK2 regulates paclitaxel resistance in triple negative breast cancers

Han, J., Yun, J., Quan, M., Kang, W., Jung, J. G., Heo, W., Li, S., Lee, K. J., Son, H., Kim, J. H., et al. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02138-3 · Cited by 32

Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy

Deng, K., Yang, D., & Zhou, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071344 · Cited by 32

Manganese oxide nano-platforms in cancer therapy: Recent advances on the development of synergistic strategies targeting the tumor microenvironment

Bonet‐Aleta, J., Calzada-Funes, J., & Hueso, J. L. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101628 · Cited by 33

Iron participated in breast cancer chemoresistance by reinforcing IL-6 paracrine loop

Li, J., He, K., Liu, P., & Xu, L. X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.064 · Cited by 32

Comprehensive analysis of expression, prognosis and immune infiltration for TIMPs in glioblastoma

Han, J., Jing, Y., Han, F., & Sun, P. (2021) · BMC Neurology · doi:10.1186/s12883-021-02477-1 · Cited by 31

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab

Benelli, R., Costa, D., Salvini, L., Tardito, S., Tosetti, F., Villa, F., Zocchi, M. R., & Poggi, A. D. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005660 · Cited by 31

Microenvironmental regulation of therapeutic response in cancer

Klemm, F., & Joyce, J. A. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 795

Tumor microenvironment as a therapeutic target in cancer

Xiao, Y. Q., & Yu, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107753 · Cited by 2,026

From immune exclusion to exhaustion: tumor microenvironment drives therapy response

Maletin, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1785587 · Cited by 16

Tumor Microenvironment and Drug Response: A Pathology–pharmacology Perspective on Mechanisms of Therapeutic Resistance

Ravichandran, S., & Vilvanathan, S. (2026) · doi:10.9734/ajmpcp/2026/v9i1402

Potential Strategies to Improve the Effectiveness of Drug Therapy by Changing Factors Related to Tumor Microenvironment

Cao, D., Naiyila, X., Li, J., Huang, Y. C., Chen, Z., Chen, B., Li, J., Guo, J., Dong, Q., Ai, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.705280 · Cited by 7